Insulet Corporation [PODD] stock is trading at $339.88, up 0.68%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PODD shares have gain 2.75% over the last week, with a monthly amount glided 17.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insulet Corporation [NASDAQ: PODD] stock has seen the most recent analyst activity on June 16, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $365. Previously, Goldman started tracking the stock with Buy rating on May 30, 2025, and set its price target to $380. On May 13, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $350 on the stock. Wolfe Research downgraded its rating to a Peer Perform. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $340 as its price target on March 06, 2025. Bernstein started tracking with a Outperform rating for this stock on November 06, 2024, and assigned it a price target of $300. In a note dated May 30, 2024, Redburn Atlantic initiated a Buy rating and provided a target price of $235 on this stock.
Insulet Corporation [PODD] stock has fluctuated between $199.68 and $337.84 over the past year. Currently, Wall Street analysts expect the stock to reach $322 within the next 12 months. Insulet Corporation [NASDAQ: PODD] shares were valued at $339.88 at the most recent close of the market. An investor can expect a potential drop of -5.26% based on the average PODD price forecast.
Analyzing the PODD fundamentals
Insulet Corporation [NASDAQ:PODD] reported sales of 2.36B for the trailing twelve months, which represents a growth of 32.88%. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.18 and Total Capital is 0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.97.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 336.74 points at the first support level, and at 333.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 342.08, and for the 2nd resistance point, it is at 344.27.
Ratios To Look Out For
For context, Insulet Corporation’s Current Ratio is 2.23. Also, the Quick Ratio is 1.79, while the Cash Ratio stands at 0.98. Considering the valuation of this stock, the price to sales ratio is 10.14, the price to book ratio is 16.35 and price to earnings (TTM) ratio is 103.44.
Transactions by insiders
Recent insider trading involved Benjamin Eric, EVP, CPXO, that happened on Aug 21 ’25 when 4263.0 shares were sold. Officer, Benjamin Eric completed a deal on Aug 21 ’25 to buy 4263.0 shares. Meanwhile, SVP, Global Operations Singh Prem sold 1343.0 shares on Aug 07 ’25.
